Generic Drugmaker Sandoz Files Anti-Dumping Complaint About Chinese Antibiotics Imports - Regional Media News
8 Articles
8 Articles
The Swiss Group intervenes at the European Commission. SRF's economic editor Nora Meuli knows the background.
Generic drugmaker Sandoz files anti-dumping complaint about Chinese antibiotics imports - Regional Media News
ZURICH, May 28 (Reuters) - Swiss generic drugmaker Sandoz filed a draft anti-dumping complaint with the European Commission over Chinese imports of the antibiotic ingredient amoxicillin, part of the penicillin family, the company said on Thursday. • Sandoz says it has the only major remaining vertically integrated production network for penicillins in Europe. • Sandoz says Chinese market-distorting behaviours include sustained below-cost pricing…
Swiss pharmaceutical group Sandoz announced today that it has filed an anti-dumping complaint with the European Union (EU), alleging dumping of raw materials for amoxicillin, a widely used antibiotic, imported from China.
Zurich – The pharmaceutical company Sandoz has announced that it has submitted a draft anti-dumping complaint to the European Commission regarding the import of Chinese ingredients for antibiotic production. The Swiss-based company, which operates a large antibiotic manufacturing plant in Austria, stated today...
Price undercutting and state subsidies: Pharmaceutical company Sandoz is complaining to the EU. The issue concerns the import of Chinese ingredients for antibiotics. The company is demanding that Brussels impose anti-dumping duties.
The Basel-based pharmaceutical giant Sandoz makes an alarm: Europe's antibiotic supply is threatened by dependence on China. 90 percent of the active ingredients come from Asia. Sandoz calls on the EU to take protective measures against cheap imports.
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
